A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Biomarkers of Disease and May ...

Dr Braunstein, when do you typically assess these patients for MRD status following their initial therapy? BRAUNSTEIN: I ...

In a real-world study involving patients with standard-risk, newly-diagnosed multiple myeloma (NDMM), there was no significant difference identified in the level of minimal residual disease (MRD) ...

Second, regulatory endpoint. As expected, MRD is increasingly being used as a primary endpoint. We now have 10 multiple myeloma studies utilizing clonoSEQ as a primary endpoint, including two ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Until this year, when a blood test was positive for biomarkers for Alzheimer’s — triggering a further sense of panic. But here’s the problem: Science can’t yet tell us whether a positive ...

A Michigan State University student living on campus has been diagnosed with bacterial meningococcal disease, according to a Nov. 11 email from University Physician Dr. Michael Brown. Bacterial ...

The study found that the price tag for the second-generation Bruton tyrosine kinase inhibitor would need to be reduced by 30% in order to be cost-effective compared with bendamustine-rituximab (R ...

Tumour biomarkers is a term used to describe many different potential markers of cancer development and progression. These markers can come in many forms for example, proteins, biochemicals, ...

Nov. 11, 2024 — Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, according to a study. While anxiety and depression are ...

Multiple Myeloma is a type of blood cancer that develops in plasma cells — white blood cells responsible for producing antibodies to fight infections. This disease affects the bone marrow, weakening ...